Prognostic significance of arterial stiffness measurements in end-stage renal disease patients

Current Opinion in Nephrology and Hypertension

Volumn 11, Issue 6, 2002, Pages 629-634

  Blacher, Jacques ^a   Safar, Michel E ^a   Pannier, Bruno ^b   Guerin, Alain P ^b   Marchais, Sylvain J ^b   London, Gérard M ^b  

^a HÔPITAL BROUSSAIS   (France)

^b F H Manhès Hospital   (France)

Author keywords

Aorta; Arterial stiffness; Cardiovascular risk; End stage renal disease; Prognosis

Indexed keywords

ADULT; AGED; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; EPIDEMIOLOGICAL DATA; HEART HEMODYNAMICS; HEMODIALYSIS; HEMODYNAMIC MONITORING; HUMAN; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PULSE PRESSURE; PULSE WAVE; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; TREATMENT OUTCOME;

ALGORITHMS; ARTERIES; CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; PROGNOSIS; RISK FACTORS;

EID: 0036860266     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-200211000-00010     Document Type: Review

References (39)

1. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998; 19:1434-1503.
2. Anderson KM, Odell PM, Wilson PWF, et al. Cardiovascular disease risk profiles. Am Heart J 1991; 121:293-298.
3. Celermajer DS. Noninvasive detection of atherosclerosis. N Engl J Med 1998; 339:2014-2015.
4. Society of Actuaries. Build and Blood Pressure Study. Chicago: Society of Actuaries; 1959.
5. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000; 355:865-872.
6. O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22.
7. Blacher J, Pannier B, Guerin A, et al. Impact of carotid stiffness on cardiovascular and all-cause mortality in end-stage renal failure. Hypertension 1998; 32:570-574.
8. Nichols WW, O'Rourke MF. Vascular impedance. In: Nichols and O'Rourke, editors. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th Ed. London: Edward Arnold; 1998. pp. 54-97, 243-283, 347-395.
9. London GM, Guerin AP, Pannier B, et al. Large artery structure and function in hypertension and end-stage renal disease. J Hypertens 1998; 12:1931-1938.
10. Berthoux F. Epidemiological data of treated end stage renal failure in the European Community (EC) during the year 1995: Report of the ERA-EDTA registry and the National Registries. Figures from Annual Report of Management of Renal Failure in Europe XXVIII; 1997. pp. 1-56.
11. London GM, Guerin AP, Marchais SJ, et al. Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996; 50:600-608.
12. Lindner A, Charra B, Sherrard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290:697-701.
13. Van Bortel LM, Duprez D, Starmans-Kool MJ, et al. Clinical applications of arterial stiffness, Task Force III: Recommendations for user procedures. Am J Hypertens 2002; 15:445-452. This recent task force gives recommendations concerning arterial stiffness measurements, especially standardization of the subject conditions and devices.
14. Mourad JJ, Pannier B, Blacher J, et al. Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001; 59:1834-1841.
15. Darné B, Girerd X, Safar M, et al. Pulsatile versus steady component of blood pressure. A cross-sectional and prospective analysis on cardiovascular mortality. Hypertension 1989; 13:392-400.
16. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension 1994; 23:395-401.
17. Scuteri A, Cacciafesta M, Di Bernardo MG, et al. Pulsatile versus steady-state component of blood pressure in elderly females: An independent risk factor for cardiovascular disease? J Hypertension 1995; 13:185-191.
18. Witteman JC, Grobbee DE, Valkenburg HA, et al. J-shaped relation between change in diastolic pressure and progression of aortic atherosclerosis. Lancet 1994; 343:504-507.
19. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure. A predictor of long-term cardiovascular mortality in a french male population. Hypertension 1997; 30:1410-1415.
20. Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160:1085-1089.
21. Benetos A, Zureik M, Morcet J, et al. A decrease in diastolic blood pressure combined with an increase in systolic blood pressure is associated with high cardiovascular mortality. J Am Coll Cardiol 2000; 35:673-680.
22. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation 2001; 103:1245-1249.
23. Alderman MH, Cohen H, Madhavan S. Distribution and determinants of cardiovascular events during 20 years of successful antihypertensive treatment. J Hypertens 1998; 16:761-769.
24. Blacher J, Asmar R, Djane S, et al. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33:1111-1117.
25. Meaume S, Rudnichi A, Lynch A, et al. Aortic pulse wave velocity as a marker of cardiovascular disease in subjects over 70 years old. J Hypertens. 2001; 19:871-877. This is the first paper suggesting that, in the elderly, arterial stiffness is an independent marker of cardiovascular risk.
26. Meaume S, Benetos A, Henry OF, et al. Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age. Arterioscler Thromb Vasc Biol. 2001; 21:2046-2050. This provides a prospective confirmation of the hypothesis presented in reference [25•].
27. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37:1236-1241. This provides a prospective confirmation of the hypothesis presented in reference [24].
28. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: A longitudinal study. Hypertension 2002; 39:10-15.
29. Klassen PS, Lowrie EG, Reddan DN, et al. Association between pulse pressure and mortality in patients undergoing hemodialysis. JAMA 2002; 287:1548-1555.
30. Blacher J, Guerin A, Pannier B, et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99:2434-2439. This is the first paper that has clearly shown that aortic stiffness is an independent predictor of cardiovascular and all-cause mortality.
31. Blacher J, Guerin AP, Pannier B, et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38:938-942. This paper shows that, over and above presence and extent of vascular calcifications, measurement of carotid arterial stiffness gives additional predictive value in terms of cardiovascular and all-cause mortality prediction.
32. Shoji T, Emoto M, Shinohara K, et al. Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease. J Am Soc Nephrol 2001; 12:2117-2124. This prospective observational study shows that the increased aortic stiffness of the ESRD patients with diabetes mellitus contributes to the higher all-cause and cardiovascular mortality rates.
33. Barenbrock M, Kosch M, Jöster E, et al. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 2002; 20:79-84. Even after renal transplantation, local (carotid) arterial stiffness measurement predicts cardiovascular risk.
34. Guerin A, Blacher J, Pannier B, et al. Impact of aortic stiffness attenuation on survival of patients in end-stage renal disease. Circulation 2001; 103:987-992. This therapeutic trial is the first study showing that the cardiovascular risk attributed to increased arterial stiffness can be reversed by antihypertensive treatment in ESRD patients; arterial stiffness measurements being not only useful for risk assessment but also in risk reduction strategies.
35. London GM, Pannier B, Guerin AP, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: Follow-up of an interventional study. J Am Soc Nephrol 2001; 12:2759-2767. This therapeutic trial demonstrated the reversibility of left ventricular hypertrophy in ESRD patients.
36. Safar ME, London GM. For the Clinical Committee of Arterial Structure and Function. Therapeutic studies and arterial stiffness in hypertension: Recommendations of the European Society of Hypertension. J Hypertens 2000; 18:1527-1535.
37. London GM, Blacher J, Pannier B, et al. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38:434-438. This is the first paper that has shown that arterial wave reflection is an independent predictor of cardiovascular and all-cause mortality in ESRD.
38. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735-738. This is the first paper that demonstrates that aortic pulse pressure and pulse pressure amplification are independent predictors of cardiovascular and all-cause mortality.
39. Guidelines subcommittee. 1999 World Health Organization: Internal Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.